Request Dataset
Contact us
Sign in
Lookup
HS API
Service Map
Crosswalk
Validation
Products
Prior Authorization
Businesses
Data Library
CMS Forms
Home
Healthcare Lookup Services
HCPCS Codes Lookup
Q0237 | Similar
HCPCS Codes Similar to Q0237
HCPCS Codes Similar to “Q0237” Code.
Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
M0237
Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
Code added date
: 20250124
Code effective date
: 20250124
TXT
|
PDF
|
XML
|
JSON
M0238
Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
Code added date
: 20250124
Code effective date
: 20250124
TXT
|
PDF
|
XML
|
JSON
Q5156
Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg
Code added date
: 20251001
Code effective date
: 20251001
TXT
|
PDF
|
XML
|
JSON
M0235
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose
Code added date
: 20251001
Code effective date
: 20251001
TXT
|
PDF
|
XML
|
JSON
M0236
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose
Code added date
: 20251001
Code effective date
: 20251001
TXT
|
PDF
|
XML
|
JSON
M0249
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
Code added date
: 20210624
Code effective date
: 20210624
TXT
|
PDF
|
XML
|
JSON
M0250
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
Code added date
: 20210624
Code effective date
: 20210624
TXT
|
PDF
|
XML
|
JSON
Q0235
Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg
Code added date
: 20251001
Code effective date
: 20251001
TXT
|
PDF
|
XML
|
JSON
Q0249
Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
Code added date
: 20210624
Code effective date
: 20210624
TXT
|
PDF
|
XML
|
JSON
A4483
Moisture exchanger, disposable, for use with invasive mechanical ventilation
Code added date
: 19990101
Code effective date
: 20030101
TXT
|
PDF
|
XML
|
JSON
E0550
Humidifier, durable for extensive supplemental humidification during ippb treatments or oxygen delivery
Code added date
: 19860101
Code effective date
: 20050701
TXT
|
PDF
|
XML
|
JSON
E0560
Humidifier, durable for supplemental humidification during ippb treatment or oxygen delivery
Code added date
: 19860101
Code effective date
: 20050701
TXT
|
PDF
|
XML
|
JSON
J3262
Injection, tocilizumab, 1 mg
Code added date
: 20110101
Code effective date
: 20110101
TXT
|
PDF
|
XML
|
JSON
Q5133
Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
Code added date
: 20240401
Code effective date
: 20241001
TXT
|
PDF
|
XML
|
JSON